Diabetes and the Risk of Multi-System Aging Phenotypes: A Systematic Review and Meta-Analysis
Open accessThe DOI matches its Crossref record; 83 of the 83 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Observational studies suggested an association between diabetes and the risk of various geriatric conditions (i.e., cognitive impairment, dementia, depression, mobility impairment, disability, falls, and urinary incontinence). However, the magnitude and impact of diabetes on older adults have not been reviewed. METHODOLOGY/PRINCIPAL FINDINGS: MEDLINE and PSYCINFO databases were searched through November 2007 for published studies, supplemented by manual searches of bibliographies of key articles. Population-based, prospective cohort studies that reported risk of geriatric outcomes in relation to diabetes status at baseline were selected. Two authors independently extracted the data, including study population and follow-up duration, ascertainment of diabetes status at baseline, outcomes of interest and their ascertainment, adjusted covariates, measures of association, and brief results. Fifteen studies examined the association of DM with cognitive dysfunction. DM was associated with a faster decline in cognitive function among older adults. The pooled adjusted risk ratio (RR) for all dementia when persons with DM were compared to those without was 1.47 (95% CI, 1.25 to 1.73). Summary RRs for Alzheimer's disease and vascular dementia comparing persons with DM to those without were 1.39 (CI, 1.16 to 1.66) and 2.38 (CI, 1.79 to 3.18), respectively. Four of 5 studies found significant association of DM with faster mobility decline and incident disability. Two studies examined the association of diabetes with falls in older women. Both found statistically significant associations. Insulin users had higher RR for recurrent falls. One study for urinary incontinence in older women found statistically significant associations. Two studies for depression did not suggest that DM was an independent predictor of incident depression. CONCLUSIONS/SIGNIFICANCE: Current evidence supports that DM is associated with increased risk for selected geriatric conditions. Clinicians should increase their awareness and provide appropriate care. Future research is required to elucidate the underlying pathological pathway.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“(3) patients at low risk for dementia (young mean age)441,445 and with high baseline MMSE;”
From Vascular Contributions to Cognitive Impairment and Dementia: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association (2011) · cites this paper as [441]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“(2) heterogeneity in screening and diagnosis of dementia441;”
From Vascular Contributions to Cognitive Impairment and Dementia: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association (2011) · cites this paper as [441]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Alzheimer’s-type and multi-infarct dementia are approximately twice as likely to occur in those with diabetes compared to age-matched non-diabetic controls59.”
From Diabetes in Older Adults: A Consensus Report (2012) · cites this paper as [59]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Four of these trials reported that treatment had no clear-cut effect on the risk of dementia440,441,443,444 or cognitive function.441,443,444”
From Vascular Contributions to Cognitive Impairment and Dementia: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association (2011) · cites this paper as [441]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Four of these trials reported that treatment had no clear-cut effect on the risk of dementia440,441,443,444 or cognitive function.441,443,444”
From Vascular Contributions to Cognitive Impairment and Dementia: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association (2011) · cites this paper as [441]
Experimental — accuracy not yet measured
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>
Stroup, D. F. (2000) · JAMA · doi:10.1001/jama.283.15.2008 · Cited by 20,623
Stearne, M. R., Palmer, S. L., Hammersley, M. S., Franklin, S. L., Spivey, R. S., Lévy, J., Tidy, C. R., Bell, N. J., Steemson, J., Barrow, B. A., et al. (1998) · UCL Discovery (University College London) · Cited by 6,090
The Pathobiology of Diabetic Complications
Brownlee, M. (2005) · Diabetes · doi:10.2337/diabetes.54.6.1615 · Cited by 5,339 · cited 2×
“Several molecular mechanisms have been proposed to explain the mediation between DM and hyperglycemia-induced tissue damage, including the advanced glycation end products (AGEs) [62].”
BackgroundEconomic Costs of Diabetes in the U.S. in 2002
American Diabetes Association (2003) · Diabetes Care · doi:10.2337/diacare.26.3.917 · Cited by 4,147
Zhang, J., & Yu, K. F. (1998) · JAMA · doi:10.1001/jama.280.19.1690 · Cited by 4,138 · cited 1×
“The adjusted odds ratios (ORs) were considered as RRs since the incidence of dementia were not common in the study population [46].”
BackgroundThe Prevalence of Comorbid Depression in Adults With Diabetes
Anderson, R. J., Freedland, K. E., Clouse, R. E., & Lustman, P. J. (2001) · Diabetes Care · doi:10.2337/diacare.24.6.1069 · Cited by 3,926 · cited 1×
“A few systematic reviews have focused on the effect of diabetes on individual geriatric outcomes [28,29], but they also presented several weaknesses, such as inclusion of cross-sectional studies or those without proper adjustment for major confounders.”
BackgroundDiabetes mellitus and the risk of dementia: The Rotterdam Study
Ott, A., Stolk, R. P., van Harskamp, F., Pols, H. A. P., Hofman, A., & Breteler, M. M. B. (1999) · Neurology · doi:10.1212/wnl.53.9.1937 · Cited by 2,175
Research works printed but not linked: 3
- Jackson SL Scholes D Boyko EJ Abraham L Fihn SD 2005 Urinary incontinence and diabetes in postmenopausal women. Diabetes Care 28 1730 1738 15983327 · DOI
- Maurer MS Burcham J Cheng H 2005 Diabetes mellitus is associated with an increased risk of falls in elderly residents of a long-term care facility. J Gerontol A Biol Sci Med Sci 60 1157 1162 16183956 · DOI · Paper page
- Wu JH Haan MN Liang J Ghosh D Gonzalez HM 2003 Diabetes as a predictor of change in functional status among older Mexican Americans: a population-based cohort study. Diabetes Care 26 314 319 12547855 · DOI · Paper page
Cited by
Items 101–200 of 398
Epidemiological Evidence of the Relationship Between Diabetes and Dementia
Ninomiya, T. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-3540-2_2 · Cited by 60
Older Adult Self-Efficacy Study of Mobile Phone Diabetes Management
Quinn, C. C., Khokhar, B., Weed, K., Barr, E., & Gruber-Baldini, A. L. (2015) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2014.0341 · Cited by 56
Abbatecola, A. M., Bo, M., Barbagallo, M., Incalzi, R. A., Pilotto, A., Bellelli, G., Maggi, S., & Paolisso, G. (2015) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2014.12.014 · Cited by 60
Yan, Y., Salazar, T. E., Dominguez, J. M., Nguyen, D. V., Calzi, S. L., Bhatwadekar, A. D., Qi, X., Busik, J. V., Boulton, M. E., & Grant, M. B. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080029 · Cited by 57
“Diabetes is considered a state of premature aging, largely due to the similarity of the vascular pathology in both situations[18].”
BackgroundThe impact of vascular burden on late-life depression
Santos, M., Kövari, E., Hof, P. R., Gold, G., Bouras, C., & Giannakopoulos, P. (2009) · Brain Research Reviews · doi:10.1016/j.brainresrev.2009.08.003 · Cited by 57
Lee, C. G., Schwartz, A. V., Yaffe, K., Hillier, T. A., LeBlanc, E. S., Cawthon, P. M., & the Study of Osteoporotic Fractures Research Group (2013) · Journal of the American Geriatrics Society · doi:10.1111/jgs.12502 · Cited by 53
Modifiable cardiovascular risk factors and genetics for targeted prevention of dementia
Rasmussen, I. J., & Frikke‐Schmidt, R. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad293 · Cited by 61
Anstey, K. J., Sargent‐Cox, K. A., Eramudugolla, R., Magliano, D. J., & Shaw, J. E. (2015) · Alzheimer s Research & Therapy · doi:10.1186/s13195-015-0131-4 · Cited by 55
“Recent research on both middle-aged adults [1] and older adults [2] has shown that type 2 diabetes increases the risk of late-life cognitive decline, Alzheimer’s disease (AD) and all-cause dementia [3–5].”
BackgroundThe association of diabetes and dementia and possible implications for nondiabetic populations
Ravona‐Springer, R., & Beeri, M. S. (2011) · Expert Review of Neurotherapeutics · doi:10.1586/ern.11.152 · Cited by 58
“Despite the robust and consistent studies demonstrating that diabetes is a risk factor for AD based on clinical assessment of dementia [22,23], some neuropathological studies have found results to the contrary, for instance, that diagnosis of diabetes is associated with less AD neuropathological hallmarks [6,24].”
ResultVaughan, C. P., Markland, A. D., Smith, P. P., Burgio, K. L., & Kuchel, G. A. (2017) · Journal of the American Geriatrics Society · doi:10.1111/jgs.15157 · Cited by 56
“In addition to delirium and insomnia, falls and mobility problems are associated with higher rates of UI.”
BackgroundInfluentialThe growing range of complications of diabetes mellitus
Hamblin, P. S., Russell, A. W., Talic, S., & Zoungas, S. (2025) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2024.12.006 · Cited by 58
Westwood, S., Liu, B., Baird, A. L., Anand, S. N., Nevado‐Holgado, A. J., Newby, D., Pikkarainen, M., Hallikainen, M., Kuusisto, J., Streffer, J. R., et al. (2017) · Alzheimer s Research & Therapy · doi:10.1186/s13195-017-0258-6 · Cited by 53
Diabetes: Risk factor and translational therapeutic implications for Alzheimer's disease
Cummings, J., Ortiz, A., Castellino, J., & Kinney, J. (2022) · European Journal of Neuroscience · doi:10.1111/ejn.15619 · Cited by 48
“Type 2 diabetes mellitus (T2DM) can confer a 1.5-fold to fourfold increase in lifetime risk for AD (Lu et al., 2009; Mehla et al., 2014).”
BackgroundInfluentialGeriatric Conditions Develop in Middle-Aged Adults with Diabetes
Cigolle, C. T., Lee, P., Langa, K. M., Lee, Y. Y., Tian, Z., & Blaum, C. S. (2010) · Journal of General Internal Medicine · doi:10.1007/s11606-010-1510-y · Cited by 54
Blennow, K., & Zetterberg, H. (2019) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2019.07.006 · Cited by 50
Impaired incretin secretion and pancreatic dysfunction with older age and diabetes
Geloneze, B., de Oliveira, M. D. S., Vasques, A. C. J., Novaes, F. S., Pareja, J. C., & Tambascia, M. A. (2014) · Metabolism · doi:10.1016/j.metabol.2014.04.004 · Cited by 52
“Life expectancy is increasing among the world population [1,2].”
BackgroundImpact of Insulin Sensitizers on the Incidence of Dementia: A Meta-Analysis
Ye, F., Luo, Y.-J., Xiao, J., Yu, N.-W., & Yi, G. (2016) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000445941 · Cited by 46
Sečník, J., Čermáková, P., Fereshtehnejad, S., Dannberg, P., Johnell, K., Fastbom, J., Winblad, B. G., Eriksdotter, M., & Religa, D. (2017) · Diabetes Care · doi:10.2337/dc16-2516 · Cited by 51
“When we stratified the analysis by the type of dementia disorder (Table 4), we found that patients with diabetes were less likely to receive CheIs when they received a diagnosis of AD (model 2: OR 0.78; 99% CI 0.63–0.95), mixed dementia (OR 0.69; 99% CI 0.56– 0.85), and VaD (OR 0.68; 99% CI 0.49– 0.95).”
BackgroundInfluentialLi, C., Zuo, Z., Liu, D., Jiang, R., Li, Y., Li, H., Yin, X., Lai, Y., Wang, J., & Xiong, K. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00856 · Cited by 45
“Therefore, early detection and diagnosis of T2DM patients with MCI (T2DM-MCI), at least 47% of whom are likely to develop dementia (Lu et al., 2009), are crucial for timely prevention and treatment.”
BackgroundAvogaro, A., Dardano, A., de Kreutzenberg, S. V., & Prato, S. D. (2014) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12319 · Cited by 49
Musculoskeletal manifestations in diabetic patients at a tertiary center
Attar, S. M. (2012) · Libyan Journal of Medicine · doi:10.3402/ljm.v7i0.19162 · Cited by 54
“Crystal arthropathy (n 7) 1 (14) 3 (43) 1 (14) 3 (43) 4 (57) 2 (29)”
Sun, C., Fan, S., Wang, X., Lu, J., Zhang, Z., Wu, D., Shan, Q., & Zheng, Y. (2015) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2015.04.012 · Cited by 43
“Indeed, vascular aging is accelerated in patients with diabetes [49], and it is reported that high glucose induces premature senescence of endothelial cells [50].”
BackgroundPaul, S. C., Saha, D., & Binukumar, B. K. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02365-2 · Cited by 46
Demakakos, P., Terrera, G. M., & Nouwen, A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0175827 · Cited by 47
Esiri, M. M., Joachim, C., Sloan, C., Christie, S., Agacinski, G., Bridges, L. R., Wilcock, G. K., & Smith, A. D. (2014) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e31829b72f1 · Cited by 42
Carvalho, C., Katz, P. S., Dutta, S., Katakam, P. V. G., Moreira, P. I., & Busija, D. W. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-130464 · Cited by 45
“39 times more likely to develop AD [26].”
Biomarkers for cognitive decline in patients with diabetes mellitus: evidence from clinical studies
Zhao, X. Y., Han, Q., Lv, Y., Sun, L., Gang, X., & Wang, G. (2017) · Oncotarget · doi:10.18632/oncotarget.23284 · Cited by 50
“Comparing with patients without diabetes, diabetic patients had 39% increased risk of Alzheimer’s disease and 47% increased risk of dementia [5, 6].”
BackgroundBRIDGING THE TRANSLATION GAP: FROM DEMENTIA RISK ASSESSMENT TO ADVICE ON RISK REDUCTION
Anstey, K. J., Eramudugolla, R., Hosking, D. E., Lautenschlager, N. T., & Dixon, R. A. (2015) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2015.75 · Cited by 44
“There is also emerging evidence that pre-diabetic and sub-clinical levels of high blood glucose also predict cognitive decline and dementia (69, 70) although there have been no meta-analyses of this association.”
BackgroundSibbett, R. A., Russ, T. C., Deary, I. J., & Starr, J. M. (2017) · BMC Psychiatry · doi:10.1186/s12888-017-1366-3 · Cited by 38
Jurcau, A., & Simion, A. (2020) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527319666200303121016 · Cited by 38
Wang, X., Yan, X., Zhang, J., Pan, S., Li, R., Cheng, L., Qi, X., Li, L., & Li, Y. (2024) · Nutrition Journal · doi:10.1186/s12937-024-01017-0 · Cited by 52
“Even though aging may be affected by diabetes and CVD [69, 70], the fundamental connection between quality meals and decelerated aging remained unchanged even when considering these chronic conditions.”
BackgroundDiabetes, hyperglycemia and the management of cerebrovascular disease
Haratz, S., & Tanné, D. (2010) · Current Opinion in Neurology · doi:10.1097/wco.0b013e3283418fed · Cited by 40
Análise comparativa do risco de quedas entre pacientes com e sem diabetes mellitus tipo 2
de Oliveira, P. P., Fachin, S. M., Tozatti, J., Ferreira, M. C., & Marinheiro, L. P. F. (2012) · Revista da Associação Médica Brasileira · doi:10.1590/s0104-42302012000200021 · Cited by 36
Youm, Y., Yang, H., Amin, R., Smith, S. R., Leff, T., & Dixit, V. D. (2010) · Aging Cell · doi:10.1111/j.1474-9726.2010.00574.x · Cited by 40
“Strikingly, approximately 20% patients over the age of 65 years have frank diabetes (Morley, 2008; Lu et al., 2009; Poulsen et al., 2009).”
Alzheimer's “Prevention” vs. “Risk Reduction”: Transcending Semantics for Clinical Practice
Hodes, J. F., Oakley, C. I., O’Keefe, J. H., Lu, P., Galvin, J. E., Saif, N., Bellara, S., Rahman, A., Kaufman, Y., Hristov, H., et al. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2018.01179 · Cited by 38
Disruption of neurogenesis by hypothalamic inflammation in obesity or aging
Purkayastha, S., & Cai, D. (2013) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-013-9279-z · Cited by 38
Liu, X., DILXAT, T., Shi, Q., Qiu, T., & Lin, J. (2022) · Gene · doi:10.1016/j.gene.2022.146348 · Cited by 34
Raffield, L. M., Cox, A. J., Freedman, B. I., Hugenschmidt, C. E., Hsu, F., Wagner, B., Xu, J., Maldjian, J. A., & Bowden, D. W. (2015) · Acta Diabetologica · doi:10.1007/s00592-015-0815-z · Cited by 38
“Type 2 diabetes (T2D) has been associated both with mild, age-related decrements in cognitive testing performance and with increased risk of Alzheimer’s disease and vascular dementia [1–3].”
How stress mediators can cumulatively contribute to Alzheimer’s disease An allostatic load approach
Matos, T. M., & Souza‐Talarico, J. N. (2019) · Dementia & Neuropsychologia · doi:10.1590/1980-57642018dn13-010002 · Cited by 38
Kotsani, M., Chatziadamidou, T., Economides, D., & Bénétos, A. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.10.026 · Cited by 31
Akimoto, H., Tezuka, K., Nishida, Y., Nakayama, T., Takahashi, Y., & Asai, S. (2019) · Pharmacology Research & Perspectives · doi:10.1002/prp2.536 · Cited by 32
Patel, R. S., Lui, A., Hudson, C., Moss, L. D., Sparks, R. P., Hill, S. E., Shi, Y., Cai, J., Blair, L. J., Bickford, P. C., et al. (2023) · Scientific Reports · doi:10.1038/s41598-022-27126-6 · Cited by 35
Mickute, M., Henson, J., Rowlands, A. V., Sargeant, J. A., Webb, D., Hall, A. P., Edwardson, C. L., Baldry, E. L., Brady, E. M., Khunti, K., et al. (2021) · Diabetic Medicine · doi:10.1111/dme.14393 · Cited by 29
“Finally, we also mutually adjusted (1) intensity gradient and physical activity volume for one another, and (2) MVPA and sedentary time for one another.”
MethodScuteri, A., & Lakatta, E. G. (2012) · Experimental Gerontology · doi:10.1016/j.exger.2012.02.009 · Cited by 35
McFall, G. P., Geall, B. P., Fischer, A. L., Dolcos, S. M., & Dixon, R. A. (2010) · Neuropsychology · doi:10.1037/a0019246 · Cited by 34
U‐shaped association between sleep duration and biological aging: Evidence from the UK Biobank study
Wang, X., Yan, X., Li, M., Cheng, L., Qi, X., Zhang, J., Pan, S., Xu, X., Wei, W., & Li, Y. (2024) · Aging Cell · doi:10.1111/acel.14159 · Cited by 32
“Even though aging can be influenced by diabetes (Lu et al., 2009), high blood pressure (Peng et al., 2017), and depression (Alexopoulos et al., 2002), the core relationship between imbalanced sleep duration and accelerated aging remained consistent even after considering these chronic conditions.”
BackgroundZhou, C., Li, J., Dong, M., Ping, L., Lin, H., Wang, Y., Wang, S., Gao, S., Yu, G., Cheng, Y., et al. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.658198 · Cited by 30
Magierski, R., Kłoszewska, I., & Sobów, T. (2010) · Neurologia i Neurochirurgia Polska · doi:10.1016/s0028-3843(14)60005-0 · Cited by 31
Lin, P.-J., Yang, Z., Fillit, H. M., Cohen, J. T., & Neumann, P. J. (2014) · Health Affairs · doi:10.1377/hlthaff.2013.1276 · Cited by 28
Treatment of Vascular Cognitive Impairment
Ritter, A. R., & Pillai, J. A. (2015) · Current Treatment Options in Neurology · doi:10.1007/s11940-015-0367-0 · Cited by 30
Prevalence of Cognitive Impairment No Dementia in a Rural Area of Northern China
Zhang, Y., Shi, Z., Liu, M., Liu, S., Yue, W., Liu, S., Xiang, L., Lü, H., Liu, P., Wısnıewskı, T., et al. (2014) · Neuroepidemiology · doi:10.1159/000360138 · Cited by 29
“mellitus, are associated with cognitive dysfunction and dementia [28] .”
Raffield, L. M., Brenes, G. A., Cox, A. J., Freedman, B. I., Hugenschmidt, C. E., Hsu, F., Xu, J., Wagner, B., Williamson, J. D., Maldjian, J. A., et al. (2015) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2015.09.010 · Cited by 32
Comparative analysis of risk for falls in patients with and without type 2 diabetes mellitus
de Oliveira, P. P., Fachin, S. M., Tozatti, J., Ferreira, M. C., & Marinheiro, L. P. F. (2012) · Revista da Associação Médica Brasileira · doi:10.1016/s0104-4230(12)70186-0 · Cited by 27
Clinical backgrounds and morbidity of cognitive impairment in elderly diabetic patients
Yamazaki, Y., Miwa, T., Sakurai, H., Hanyu, H., Iwamoto, T., & Odawara, M. (2011) · Endocrine Journal · doi:10.1507/endocrj.k10e-388 · Cited by 27
“A recent systematic review [4] indicated that patients with diabetes are at a 1.”
BackgroundKoye, D. N., Shaw, J. E., & Magliano, D. J. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.01.016 · Cited by 32
Beverly, E. A., Ritholz, M. D., Shepherd, C., & Weinger, K. (2016) · Current Diabetes Reports · doi:10.1007/s11892-016-0741-7 · Cited by 33
Hazar, N., Seddigh, L., Rampisheh, Z., & Nojomi, M. (2016) · PubMed Central · Cited by 33
Yang, T., Zhang, L., Yi, L., Feng, H., Li, S., Chen, H., Zhu, J., Zhao, J. H., Zeng, Y., & Liu, H. (2020) · JMIR Medical Informatics · doi:10.2196/15431 · Cited by 27
Pharmacological Approaches Using Diabetic Drugs Repurposed for Alzheimer’s Disease
Adem, M. A., Decourt, B., & Sabbagh, M. N. (2024) · Biomedicines · doi:10.3390/biomedicines12010099 · Cited by 34
“Following the initial Rotterdam study, in which there was a positive association between dementia and T2DM [18], additional epidemiological and clinical studies have been conducted in an attempt to establish a more concrete causal link between the two disorders [19,20].”
ResultInfluentialRosso, A. L., Eaton, C. B., Wallace, R. B., Gold, R. B., Curb, J. D., Stefanick, M. L., Ockene, J. K., & Michael, Y. L. (2011) · The Journals of Gerontology Series A · doi:10.1093/gerona/glq230 · Cited by 31
“However, in a meta-analysis, diabetes was shown to be a risk factor for incidence of several GS, including dementia, mobility decline, disability, falls, and UI but not depression (5).”
BackgroundWennberg, A. M. V., Gottesman, R. F., Kaufmann, C. N., Albert, M., Chen-Edinboro, L. P., Rebok, G. W., Kasper, J. D., & Spira, A. P. (2014) · International Psychogeriatrics · doi:10.1017/s1041610214001380 · Cited by 24
“We also conducted a sensitivity analysis: specifically, because stroke is a possible mechanism by which DM may affect cognition (Lu et al., 2009), we excluded participants with history of stroke and repeated analyses without stroke as a covariate (Model 2).”
Jafari, N., Shoaibinobarian, N., Dehghani, A., Rad, A., Mirmohammadali, S. N., Alaeian, M. J., Hamedi, Y., Zamani, M. M., Goudarzi, M. A., & Asbaghi, O. (2023) · Food Science & Nutrition · doi:10.1002/fsn3.3311 · Cited by 29
“Dose– response relations between duration of intervention (week) and absolute mean differences in FBS (mg/dL). health and cognitive functioning, as well as hepatic, digestive, and musculoskeletal systems are affected by diabetes (Lu et al., 2009).”
BackgroundMoulton, C. D., Stewart, R. J., Amiel, S. A., Laake, J.-P., & Ismail, K. (2015) · Aging & Mental Health · doi:10.1080/13607863.2015.1040723 · Cited by 28
Shi, Z., Zhang, Y., Yue, W., Liu, M., Huo, Y. R., Liu, S., Liu, S., Xiang, L., Liu, P., Lü, H., et al. (2013) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000350811 · Cited by 29
Muñoz‐Rivas, N., Méndez‐Bailón, M., de Miguel-Yanes, J. M., Hernández‐Barrera, V., de Miguel‐Díez, J., Jiménez‐García, R., & López‐de‐Andrés, A. (2017) · BMJ Open · doi:10.1136/bmjopen-2017-016390 · Cited by 24
“Furthermore, recent reports suggest that patients with diabetes have a 60% higher risk for developing dementia.(10) Age, smoking, hypertension and diabetes, all represent factors linked to strengths and limitations of this study”
BackgroundKopp, K. O., Li, Y., Glotfelty, E. J., Tweedie, D., & Greig, N. H. (2024) · Biomolecules · doi:10.3390/biom14070872 · Cited by 27
Cognitive disorders in diabetic patients
Koekkoek, P. S., Rutten, G. E. H. M., & Biessels, G. J. (2014) · Handbook of clinical neurology · doi:10.1016/b978-0-444-53480-4.00011-4 · Cited by 28
Diabetes Care and Dementia Among Older Adults: A Nationwide 3-Year Longitudinal Study
Wargny, M., Gallini, A., Hanaire, H. P., Nourhashémi, F., Andrieu, S., & Gardette, V. (2018) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2017.12.006 · Cited by 27
“In this study, dementia was defined by the first recording of one of the following criteria: (1) LTD registration for ADRS [International Classification of Diseases, 10th Revision (ICD-10) codes: F00-F03, G30, G31]; (2) hospital stay reporting a diagnosis code of ADRS (similar ICD-10 codes); or (3) reimbursement for a…”
BackgroundMethodThe factors associated with cognitive function among community-dwelling older adults in Taiwan
Lor, Y.-C., Tsou, M.-T., Tsai, L., & Tsai, S.-Y. (2023) · BMC Geriatrics · doi:10.1186/s12877-023-03806-4 · Cited by 31
“Diabetes mellitus as a risk factor for cognitive impairment has been studied previously [14, 15].”
BackgroundGasquoine, P. G. (2011) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803395.2010.536759 · Cited by 24
Relationship between metformin and frailty syndrome in elderly people with type 2 diabetes.
Sumantri, S., Setiati, S., Purnamasari, D., & Dewiasty, E. (2014) · Acta medica Indonesiana · Cited by 33
Wennberg, A. M. V., Hagen, C. E., Gottesman, R. F., Zipunnikov, V. M., Kaufmann, C. N., Albert, M., Rebok, G. W., Kasper, J. D., & Spira, A. P. (2017) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2017.05.005 · Cited by 25
Exercise attenuates the premature cardiovascular aging effects of type 2 diabetes mellitus
Huebschmann, A. G., Kohrt, W. M., & Regensteiner, J. G. (2011) · Vascular Medicine · doi:10.1177/1358863x11419996 · Cited by 27
Wen, Y.-H., Wu, S. S., Lin, C. R., Tsai, J., Yang, P., Chang, Y., & Tseng, K.-H. (2016) · Medicine · doi:10.1097/md.0000000000003658 · Cited by 25
Kwon, B., Gamache, T., Lee, H., & Querfurth, H. W. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.05.012 · Cited by 25
Willis, K. J., & Hakim, A. M. (2013) · Frontiers in Neurology · doi:10.3389/fneur.2013.00013 · Cited by 26
“…studies find evidence for the association of modifiable vascular risk factors such as mid-life hypertension (Nagai et al., 2010), diabetes (Lu et al., 2009), cholesterol (van Vliet, 2012), poor diet (Solfrizzi et al., 2011), obesity (Lee, 2011), physical inactivity (Denkinger et al.,…”
BackgroundGender Differences in Physical Activity Levels of Older People With Type 2 Diabetes Mellitus
Kelly, J., Edney, K., Moran, C., Srikanth, V. K., & Callisaya, M. L. (2015) · Journal of Physical Activity and Health · doi:10.1123/jpah.2015-0147 · Cited by 26
Xie, C., Zhong, D., Zhang, Y., Liu, X., Zhang, L., Luo, X. L., Gong, Y., Jiang, W., Jin, R., & Li, J. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2023.1271437 · Cited by 23
Diabetes-related disability as a target for prevention
Gregg, E. W. (2013) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70054-8 · Cited by 20
Correia, B., Fernandes, J., Botica, M. J., Ferreira, C., & Quintas, A. (2022) · Medicines · doi:10.3390/medicines9030019 · Cited by 27
ABO Blood Group and Dementia Risk – A Scandinavian Record-Linkage Study
Vasan, S. K., Rostgaard, K., Ullum, H., Melbye, M., Hjalgrim, H., & Edgren, G. (2015) · PLoS ONE · doi:10.1371/journal.pone.0129115 · Cited by 21
“[1] Both cognitive impairment and dementia are inter-related as they share several putative risk factors in common, including age, smoking,[2] chronic alcohol abuse,[3] obesity, [4] hypertension,[5] dyslipidemia,[6] and diabetes.[7] Recent evidences have highlighted the significance of certain common pathological mech…”
BackgroundUser perceptions of a dementia risk reduction website and its promotion of behavior change
Farrow, M. (2013) · JMIR Research Protocols · doi:10.2196/resprot.2372 · Cited by 19
Prevention in Psychiatry: Effects of Healthy Lifestyle on Cognition
Merrill, D. A., & Small, G. W. (2010) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2010.11.009 · Cited by 21
Jung, M. E., & Mallet, R. T. (2017) · Respiratory Physiology & Neurobiology · doi:10.1016/j.resp.2017.08.007 · Cited by 24
“AD risk factors include comorbidities of obesity: type 2 diabetes mellitus (Lu et al., 2009; Li et al., 2015), hypertension (Di Iorio et al.”
BackgroundBuch, A., Eldor, R., Kis, O., Keinan‐Boker, L., Dunsky, A., Rubin, A., Lopez, A., Sofer, Y., Osher, E., Marcus, Y., et al. (2019) · BMC Geriatrics · doi:10.1186/s12877-019-1219-7 · Cited by 20
“The risk for T2DM related complications is age related and is accompanied by functional limitation and comorbidities [7, 8].”
Pathogenesis of Drug-Resistant Hypertension
Townsend, R. R. (2014) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2014.08.004 · Cited by 23
Hong, X., Chen, X., Chu, J., Shen, S., Chai, Q., Lou, G., & Chen, L. (2017) · Clinical Interventions in Aging · doi:10.2147/cia.s123985 · Cited by 19
Physiological Changes in Older Adults and Their Effect on Diabetes Treatment
Gates, B. J., & Walker, K. M. (2014) · Diabetes Spectrum · doi:10.2337/diaspect.27.1.20 · Cited by 23
Dissecting the Brain/Islet Axis in Metabesity
Fuente-Martín, E., Mellado‐Gil, J. M., Cobo‐Vuilleumier, N., Martín‐Montalvo, A., Romero‐Zerbo, S., Contreras, I. D., Hmadcha, A., Soria, B., Bermudo, F. M., Reyes, J. C., et al. (2019) · Genes · doi:10.3390/genes10050350 · Cited by 21
“In agreement with this, epidemiological and clinical evidence suggests that metabesity and T2DM are associated with cognitive decrements, as well as increased risk for dementia [175,176].”
BackgroundCognitive Function and Falls in Older Adults With Type 2 Diabetes Mellitus
Blackwood, J. (2018) · Journal of Geriatric Physical Therapy · doi:10.1519/jpt.0000000000000209 · Cited by 18
Managing diabetes in people with dementia: a realist review
Bunn, F., Goodman, C. M., Jones, P. R., Russell, B., Trivedi, D. P., Sinclair, A. J., Bayer, A. J., Rait, G., Rycroft‐Malone, J., & Burton, C. R. (2017) · Health Technology Assessment · doi:10.3310/hta21750 · Cited by 23
Raisi‐Estabragh, Z., M'Charrak, A., McCracken, C., Biasiolli, L., Ardissino, M., Curtis, E., Aung, N., Suemoto, C. K., Mackay, C. E., Suri, S., et al. (2021) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jeab075 · Cited by 15
Assessment of glycemic control in nursing home residents with diabetes
Rétornaz, F., Grino, M., Mari, L., & Oliver, C. (2016) · The journal of nutrition health & aging · doi:10.1007/s12603-016-0776-0 · Cited by 20
“The influence of hyperglycemia on cognitive function and neurodegenerative diseases was suspected in several epidemiological studies (36, 37).”
Xu, W., Pedersen, N. L., Keller, L., Kalpouzos, G., Wang, H., Graff, C., Winblad, B. G., Bäckman, L., & Fratiglioni, L. (2015) · PLoS Medicine · doi:10.1371/journal.pmed.1001853 · Cited by 18
Animal Research for Alzheimer Disease: Failures of Science and Ethics
Pippin, J. J., Cavanaugh, S. E., & Pistollato, F. (2019) · BRILL eBooks · doi:10.1163/9789004391192_021 · Cited by 17
Sex differences in the impact of diabetes on the risk of geriatric conditions
Lu, F., Chan, D., Kuo, H., & Wu, S. (2012) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/j.1447-0594.2012.00870.x · Cited by 18
Self-citationde Vargas, L. D. S., de Lara, M. V. S., & Mello‐Carpes, P. B. (2014) · Revista Brasileira de Geriatria e Gerontologia · doi:10.1590/1809-9823.2014.13178 · Cited by 19
Nugent, S., Potvin, O., Cunnane, S. C., Chen, T., & Duchesne, S. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.580633 · Cited by 14
“A 2009 meta-analysis by Lu et al. (2009) calculated that individuals with T2D were 39% more likely to develop AD than non-diabetics; reports since then have confirmed this finding.”
Ho, N., Brookshire, B. R., Clark, J. E., & Lucki, I. (2014) · Metabolic Brain Disease · doi:10.1007/s11011-014-9611-7 · Cited by 19
“2005) and depressed mood (Egede 2006; Holt et al. 2014; Lu et al. 2009).”
BackgroundProtective effect of different flavonoids against endothelial senescence via NLRP3 inflammasome
Sun, C., Wang, X., Zheng, G., Fan, S., Lu, J. L., Zhang, Z., Wu, D., Shan, Q., Hu, B., & Zheng, Y. (2016) · Journal of Functional Foods · doi:10.1016/j.jff.2016.08.031 · Cited by 15
Metadata
- Authors
- Lu, F.-P., Lin, K.-P., & Kuo, H.-K.
- Affiliations
- National Taiwan University (TW)
- National Health Research Institutes (TW)
- Corresponding author
- Kuo, Hsu-Ko
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2009-01-07
- Volume
- 4
- Issue
- 1
- Pages
- e4144
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC2607544
- OpenAlex
- W1993533355
- Cited by
- 398
- References
- 83
- Citations by year
- 2026: 9 · 2025: 10 · 2024: 16 · 2023: 21 · 2022: 14 · 2021: 13 · 2020: 20 · 2019: 19 · 2018: 26 · 2017: 36 · 2016: 27 · 2015: 45 · 2014: 40 · 2013: 37 · 2012: 29
- FWCI
- 2.69
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Health Research Institutes
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Epidemiology › Chronic Disease Management Strategies
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Aging, Health, and Disability
- Keywords
- diabetes mellitus, geriatric conditions, cognitive impairment, dementia, Alzheimer's disease, vascular dementia, mobility decline, disability, falls, urinary incontinence, depression, insulin therapy, older adults
- MeSH terms
- Aging, Diabetes Mellitus, Type 2, Humans, Phenotype, Risk Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

